Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Document Type
- Journal article (21)
Language
- English (21)
Keywords
- heart failure (6)
- echocardiography (3)
- ischemic stroke (3)
- acute heart failure (2)
- amyloidosis (2)
- ejection fraction (2)
- guideline adherence (2)
- left ventricular ejection fraction (2)
- myocardial work (2)
- Alzheimer’s dementia (1)
- Brain atrophy (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- Cardiovascular risk factors (1)
- Cardiovascular risk prediction (1)
- Carotid intima-media thickness (CIMT) (1)
- Carotid segment (1)
- Carotid ultrasound (1)
- Chronic heart failure (1)
- Cognitive decline (1)
- GFAP (1)
- Glial fibrillary acidic protein (1)
- Heart failure (1)
- LV dilatation (1)
- Memory dysfunction (1)
- SGLT2 inhibitors (1)
- Stroke (1)
- Troponin (1)
- accuracy (1)
- adaptive immune response (1)
- age (1)
- anti-myocardial (1)
- arterial stiffening (1)
- atherosclerosis (1)
- autoantibody (1)
- awareness (1)
- biomarkers (1)
- calcification (1)
- cardiac imaging (1)
- cardiac training group (1)
- cardiac transplantation (1)
- cardiovascular risk factors (1)
- carotid artery disease (1)
- chronic kidney disease (1)
- coaptation line (1)
- cognitive impairment (1)
- comparability (1)
- computed tomography (1)
- coronary artery disease (1)
- coronary heart disease (1)
- deformation (1)
- disease score (1)
- disease severity (1)
- dynamic (1)
- euroaspire (1)
- expert opinion (1)
- feasibility (1)
- functional regurgitation (1)
- guideline implementation (1)
- heart failure training group (1)
- hypertension (1)
- inflammation (1)
- ischemic (1)
- leaflet (1)
- left ventricular geometric abnormality (1)
- left ventricular geometry (1)
- left ventricular mass (1)
- left ventricular performance (1)
- left ventricular remodeling (1)
- m exercise training (1)
- magnetic resonance imaging (1)
- mineralocorticoid antagonist (1)
- mitral valve (1)
- morbidity (1)
- mortality (1)
- myocardial work efficiency (1)
- natriuretic peptide (1)
- neurofilament light chain (1)
- normal values (1)
- pharmacotherapy (1)
- phosphorylated tau protein (1)
- point-of-care echocardiography (1)
- population-based study (1)
- preserved ejection fraction (1)
- prevalence (1)
- primary prevention (1)
- prognosis (1)
- recovery (1)
- reference data (1)
- regression analysis (1)
- renal function (1)
- risk factor control (1)
- sex differences (1)
- stem cell transplantation (1)
- stroke unit (1)
- systolic dysfunction (1)
- tenting (1)
- therapeutic approach (1)
- three-dimensional echocardiography (1)
- transient ischemic attack (1)
- troponin (1)
Institute
- Medizinische Klinik und Poliklinik I (18)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (13)
- Institut für Klinische Epidemiologie und Biometrie (10)
- Neurologische Klinik und Poliklinik (6)
- Medizinische Klinik und Poliklinik II (3)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Informatik (1)
- Institut für Sportwissenschaft (1)
- Institut für Virologie und Immunbiologie (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Pathologisches Institut (1)
Sonstige beteiligte Institutionen
Prospective longitudinal follow‐up of left ventricular ejection fraction (LVEF) trajectories after acute cardiac decompensation of heart failure is lacking. We investigated changes in LVEF and covariates at 6‐months' follow‐up in patients with a predischarge LVEF ≤40%, and determined predictors and prognostic implications of LVEF changes through 18‐months' follow‐up.
Methods and Results
Interdisciplinary Network Heart Failure program participants (n=633) were categorized into subgroups based on LVEF at 6‐months' follow‐up: normalized LVEF (>50%; heart failure with normalized ejection fraction, n=147); midrange LVEF (41%–50%; heart failure with midrange ejection fraction, n=195), or persistently reduced LVEF (≤40%; heart failure with persistently reduced LVEF , n=291). All received guideline‐directed medical therapies. At 6‐months' follow‐up, compared with patients with heart failure with persistently reduced LVEF, heart failure with normalized LVEF or heart failure with midrange LVEF subgroups showed greater reductions in LV end‐diastolic/end‐systolic diameters (both P<0.001), and left atrial systolic diameter (P=0.002), more increased septal/posterior end‐diastolic wall‐thickness (both P<0.001), and significantly greater improvement in diastolic function, biomarkers, symptoms, and health status. Heart failure duration <1 year, female sex, higher predischarge blood pressure, and baseline LVEF were independent predictors of LVEF improvement. Mortality and event‐free survival rates were lower in patients with heart failure with normalized LVEF (P=0.002). Overall, LVEF increased further at 18‐months' follow‐up (P<0.001), while LV end‐diastolic diameter decreased (P=0.048). However, LVEF worsened (P=0.002) and LV end‐diastolic diameter increased (P=0.047) in patients with heart failure with normalized LVEF hospitalized between 6‐months' follow‐up and 18‐months' follow‐up.
Conclusions
Six‐month survivors of acute cardiac decompensation for systolic heart failure showed variable LVEF trajectories, with >50% showing improvements by ≥1 LVEF category. LVEF changes correlated with various parameters, suggesting multilevel reverse remodeling, were predictable from several baseline characteristics, and were associated with clinical outcomes at 18‐months' follow‐up. Repeat hospitalizations were associated with attenuation of reverse remodeling."